Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Teshamae S. Monteith"'
Autor:
Paige Kalika, Teshamae S. Monteith
Publikováno v:
Life, Vol 14, Iss 6, p 724 (2024)
Purpose of review: New daily persistent headache (NDPH) is a primary headache disorder characterized by the sudden onset of continuous pain and its intractability to treatment. It is more prevalent in the pediatric population than the adult populatio
Externí odkaz:
https://doaj.org/article/aefad2880d4c44638aaf4b987db102f2
Autor:
Teshamae S. Monteith, Alit Stark-Inbar, Sharon Shmuely, Dagan Harris, Sandy Garas, Alon Ironi, Paige Kalika, Samantha L. Irwin
Publikováno v:
Frontiers in Pain Research, Vol 4 (2023)
IntroductionMigraine is a chronic neurological disease manifesting as attacks of disabling head pain and associated symptoms. Remote electrical neuromodulation (REN) is a non-pharmacological, prescribed, wearable device (Nerivio®). This device has b
Externí odkaz:
https://doaj.org/article/866d3e42c25941579dc64914a8397298
Publikováno v:
Brain Sciences, Vol 8, Iss 2, p 29 (2018)
The goal of this review is to explore the literature reports of acute confusional migraine (ACM) including patient characteristics, migraine symptomatology, and proposed diagnostic criteria. A literature review was conducted using PubMed, Scopus and
Externí odkaz:
https://doaj.org/article/3ffc562f0d6f44b2a4a8cb6bb5a4f0cf
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:275-282
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0153bc5851fa64ef12914460be0b7a65
https://doi.org/10.1111/head.14458
https://doi.org/10.1111/head.14458
Publikováno v:
Current Pain and Headache Reports. 26:895-918
The aim of this review is to characterize headache as a vaccine adverse event (VAE) in clinical trials.Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13 infectious agents). The median rate (interquartile range)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04aac6970aa4a94ba8156e52e33bebda
https://doi.org/10.1007/s11916-022-01094-y
https://doi.org/10.1007/s11916-022-01094-y
Publikováno v:
Current Pain and Headache Reports. 26:555-566
There are notable health disparities and inequities in individuals with traumatic brain injury (TBI) and concussion by race, ethnicity, gender, socioeconomic status, and geography. This review will evaluate these disparities and inequities and assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084c9ef6e08f3ba2e42c2f7a9e572e14
https://doi.org/10.1007/s11916-022-01058-2
https://doi.org/10.1007/s11916-022-01058-2
Autor:
Teshamae S. Monteith, Dharani Mudugal
Publikováno v:
Expert Review of Neurotherapeutics. 21:145-155
Introduction: Cluster headache [CH] is a severely disabling trigeminal autonomic cephalalgia [TAC]. Approximately 1 in 1,000 adults are affected by CH. Calcitonin gene-related peptide [CGRP] is an ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31d3b4a3c27de01557c532a32325a52a
https://doi.org/10.1080/14737175.2021.1852931
https://doi.org/10.1080/14737175.2021.1852931
Publikováno v:
Cephalalgia. 43:033310242211435
Background Alopecia is associated with erenumab post-marketing, but no cases have been described. Methods We describe two patients that reported temporary hair loss and review the FDA Adverse Event Reporting System (FAERS). Results The first patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::868ef76201eb5892990ebe421ba23048
https://doi.org/10.1177/03331024221143538
https://doi.org/10.1177/03331024221143538
Publikováno v:
Current treatment options in neurology. 24(1)
This is an update of headache attributed to systemic disease and current therapeutic strategies. Clinical scenarios are discussed.The diagnosis of headache attributed to metabolic or systemic disorder appears in the Appendix of International Classifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2e9001d98dde25c352ae20b5fb70da
https://pubmed.ncbi.nlm.nih.gov/35317303
https://pubmed.ncbi.nlm.nih.gov/35317303
Autor:
Joel H. Saltz, Tellen D. Bennett, Emily R. Pfaff, George D. Vavougios, Sebastian Köhler, Joel J. Gagnier, Melissa Haendel, Chen Liang, Madeline A Rock, Peter N. Robinson, Anupam A Sule, Farrukh M. Koraishy, Carolyn T. Bramante, Julian Solway, Hongfang Liu, Umit Topaloglu, Heidi Spratt, Douglas S McNair, Tiffany J. Callahan, Teshamae S. Monteith, Wesley Kimble, Lauren E Chan, Julie A. McMurry, James Brian Byrd, Casey S. Greene, Richard A. Moffitt, Alfred J. Anzalone, Ann M. Parker, Ben Coleman, Mallory A Perry, Charisse R. Madlock-Brown, Robert A Schuff, Feifan Liu, Rachel R Deer, Vithal Madhira, Hannah E. Davis, Marc D. Basson, Timothy Bergquist, Halie M. Rando, Ramakanth Kavuluru, Diego R. Mazzotti, Nicole Vasilevsky, Anthony Solomonides, Liwei Wang, Leigh C. Carmody, Nicolas Matentzoglu, Eilis A. Boudreau, Justin T. Reese, Gary S. Stein, William B. Hillegass, Christopher G. Chute, Haitao Chu
Publikováno v:
EBioMedicine, Vol 74, Iss, Pp 103722-(2021)
EBioMedicine
EBioMedicine
Background Numerous publications describe the clinical manifestations of post-acute sequelae of SARS-CoV-2 (PASC or "long COVID"), but they are difficult to integrate because of heterogeneous methods and the lack of a standard for denoting the many p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c80e9ea825d50530a246efe6491b6119
http://www.sciencedirect.com/science/article/pii/S2352396421005168
http://www.sciencedirect.com/science/article/pii/S2352396421005168